FDA
approval
· 2021-12-20
FDA Approved: APRETUDE — Original Application (ViiV Healthcare Company)
Summary
FDA approved APRETUDE (cabotegravir) for HIV pre-exposure prophylaxis (PrEP) to reduce the risk of acquiring HIV-1 infection in adults and in adolescents weighi…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for APRETUDE (CABOTEGRAVIR)